Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_assertion type Assertion NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_head.
- NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_assertion description "[In this pilot investigation, we found an increased prevalence of the CYP2C8*4 mutation in the Type 2 diabetic patient group. This may result in a modification of drug degradation and drug efficacy in these patients and may have an influence, e.g. on the choice of anti-diabetic drugs. However, further trials are necessary in order to confirm our findings.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_provenance.
- NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_assertion evidence source_evidence_literature NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_provenance.
- NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_assertion SIO_000772 20857895 NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_provenance.
- NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_assertion wasDerivedFrom gad-20130706 NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_provenance.
- NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_assertion wasGeneratedBy ECO_0000203 NP59994.RADRqKxk8I85WJu9GpY3tR2PzgLNe0CqwBR5ZwrpNBXww130_provenance.